A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients
Crossref DOI link: https://doi.org/10.1007/s12149-019-01359-4
Published Online: 2019-04-13
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koizumi, Mitsuru http://orcid.org/0000-0002-8128-9760
Motegi, Kazuki
Umeda, Takuro
Text and Data Mining valid from 2019-04-13
Article History
Received: 27 January 2019
Accepted: 5 April 2019
First Online: 13 April 2019